Skip to main content

Advertisement

ADVERTISEMENT

Conference Coverage

Dr David Schwartz
Conference Coverage
06/21/2021
David Schwartz, MD, explained the challenges faced in treating perianal Crohn disease and the promise of future advances in his presentation to the Advances in Inflammatory Bowel Diseases virtual regional meeting on June 19.
David Schwartz, MD, explained the challenges faced in treating perianal Crohn disease and the promise of future advances in his presentation to the Advances in Inflammatory Bowel Diseases virtual regional meeting on June 19.
David Schwartz, MD, explained...
06/21/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

Dr Bincy Abraham
Insights from AIBD
06/19/2021
In this video, Dr Abraham, from Houston Methodist Weill Cornell, recaps a few highlights from her AIBD presentation on biosimilars.
In this video, Dr Abraham, from Houston Methodist Weill Cornell, recaps a few highlights from her AIBD presentation on biosimilars.
In this video, Dr Abraham, from...
06/19/2021
Advances in Inflammatory Bowel Disease Network
Glassner
Conference Coverage
06/19/2021
Dr Glassner, from the Fondren IBD Center at Houston Methodist Hospital, reviews the findings to date of the PIANO study on the safety of biologics and thiopurines in the management of inflammatory bowel diseases among pregnant women. She...
Dr Glassner, from the Fondren IBD Center at Houston Methodist Hospital, reviews the findings to date of the PIANO study on the safety of biologics and thiopurines in the management of inflammatory bowel diseases among pregnant women. She...
Dr Glassner, from the Fondren...
06/19/2021
Advances in Inflammatory Bowel Disease Network
Regueiro
Video
06/19/2021
In this video, Dr Miguel Regueiro recaps highlights from his discussion on the positioning of sphingosine 1-phosphate receptor modulators for inflammatory bowel disease, presented at the Advances in Inflammatory Bowel Disease 2021 regional...
In this video, Dr Miguel Regueiro recaps highlights from his discussion on the positioning of sphingosine 1-phosphate receptor modulators for inflammatory bowel disease, presented at the Advances in Inflammatory Bowel Disease 2021 regional...
In this video, Dr Miguel...
06/19/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

Video
06/19/2021
Dr Glassner, from Houston Methodist Hospital, discusses her presentation at the Advances in Inflammatory Bowel Diseases virtual regional meeting on the positioning and use of interleukin-12/23 inhibitors in the management on inflammatory...
Dr Glassner, from Houston Methodist Hospital, discusses her presentation at the Advances in Inflammatory Bowel Diseases virtual regional meeting on the positioning and use of interleukin-12/23 inhibitors in the management on inflammatory...
Dr Glassner, from Houston...
06/19/2021
Advances in Inflammatory Bowel Disease Network
Wang jpeg
Conference Coverage
06/16/2021
Dr Wang, from the University of Texas MD Anderson Cancer Center, reviews her presentation at the June 19 Advances in Inflammatory Bowel Diseases virtual regional meeting on managing Clostridiodes difficile among patients with IBD.
Dr Wang, from the University of Texas MD Anderson Cancer Center, reviews her presentation at the June 19 Advances in Inflammatory Bowel Diseases virtual regional meeting on managing Clostridiodes difficile among patients with IBD.
Dr Wang, from the University of...
06/16/2021
Advances in Inflammatory Bowel Disease Network
Chiorean
Conference Coverage
05/23/2021
Dr Chiorean, from Swedish Medical Center in Seattle, discusses his presentation at Digestive Disease Week on the promise of S1P modulators for the treatment of ulcerative colitis.
Dr Chiorean, from Swedish Medical Center in Seattle, discusses his presentation at Digestive Disease Week on the promise of S1P modulators for the treatment of ulcerative colitis.
Dr Chiorean, from Swedish...
05/23/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

SEAVUE Trial Compares Adalimumab and Ustekinumab in Crohn Disease
Conference Coverage
05/23/2021
Bruce Sands, MD, from the Icahn School of Medicine at Mt Sinai in New York, delivered eagerly awaited results of a major trial of biologics for treatment of Crohn disease at the Digestive Disease Week meeting May 23.
Bruce Sands, MD, from the Icahn School of Medicine at Mt Sinai in New York, delivered eagerly awaited results of a major trial of biologics for treatment of Crohn disease at the Digestive Disease Week meeting May 23.
Bruce Sands, MD, from the Icahn...
05/23/2021
Advances in Inflammatory Bowel Disease Network
Drinks
Conference Coverage
05/20/2021
Total consults were down for overall gastrointestinal disease, but higher for those related to alcohol, during the COVID-19 pandemic, according to research presented at the Digestive Disease Week virtual conference.
Total consults were down for overall gastrointestinal disease, but higher for those related to alcohol, during the COVID-19 pandemic, according to research presented at the Digestive Disease Week virtual conference.
Total consults were down for...
05/20/2021
Advances in Inflammatory Bowel Disease Network
Gil Y. Melmed, MD, on Personalizing Care Through Standardizing Care With Biologic Therapies in IBD
Videos
04/18/2021
Dr Melmed, from Cedars-Sinai Medical Center in Los Angeles, discusses his presentation from the virtual 2021 Interdisciplinary Autoimmune Summit on how standardizing some aspects of biologic therapies can lead to more personalized care for...
Dr Melmed, from Cedars-Sinai Medical Center in Los Angeles, discusses his presentation from the virtual 2021 Interdisciplinary Autoimmune Summit on how standardizing some aspects of biologic therapies can lead to more personalized care for...
Dr Melmed, from Cedars-Sinai...
04/18/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement